FDA warns against use of Pfizer’s Revatio in children

While the drug has never been approved for treatment of PAH in children, the U.S. Food and Drug Administration’s warning is against off-label use of the drug.

Revatio, which has the same active ingredient as Pfizer’s erectile dysfunction drug Viagra, is used to improve the ability to exercise in people with PAH — or high blood pressure in the vessels carrying blood to the lungs.

The FDA said the recommendation against the use of the drug is based on a recent clinical trial, and the Revatio drug label will carry the warning.

(Reporting by Prateek Kumar in Bangalore; Editing by Maju Samuel)

http://reut.rs/SXLTJE

• Category
• Health update

• Tags

• By
• Hitap

Related Posts

Limited resources and cutting-edge technology infiltrating every role mark the beginning of the health prioritization at the “Priorities 2024 Conference.

As our planet is with limited resources, health services to be provided must be prioritized.

Empowering Ghana’s Path to Sustainable Healthcare: HITAP’s HTA Capacity Building Workshop in Ghana